Brief: DG Sanco confirms FMD safety features timeline
The European Commission has confirmed that the delegated act on safety features for medicines will be published before the end of the year.
It is now finalising the drafting of the delegated act - on the basis of the outcome of the impact assessment, and after extensive consultation of the Member State expert group - and expects to adopt it before the end of the second quarter. That puts the act on track to become applicable in the first half of 2018.
Confirmation of the timelines comes from the minutes of the March 17 meeting of DG Sanco's Pharmaceutical Committee, which can be downloaded here.
Related articles:
Want our news sent directly to your inbox?
© SecuringIndustry.com
Sponsored Content
Could you take SecuringIndustry.com forward to new heights?
After more than 15 years of publishing SecuringIndustry.com, its co-founders have decided to move on to other projects, and it is time to pass the brand and publication on to new owners who can take it forward editorially and commercially. If you would like more information about the opportunity, please contact us at info@securingindustry.com.
Sponsored Content
Could you take SecuringIndustry.com forward to new heights?
After more than 15 years of publishing SecuringIndustry.com, its co-founders have decided to move on to other projects, and it is time to pass the brand and publication on to new owners who can take it forward editorially and commercially. If you would like more information about the opportunity, please contact us at info@securingindustry.com.
Press Releases
-
》 LSPedia Awarded National DSCSA Compliance Agreement with Premier, Inc
-
》 Biocair looks to the future of drug development and distribution with a new process for risk mitigation in supply chains
-
》 Systech launches innovative exceptions handling and rework solution
-
》 Metrc announces new track-and-trace government contract with the Commonwealth of Kentucky
Partners
| back to top